Henry Meds provides detailed program terms, but the detail needs careful interpretation. Monthly billing, total supply and shipping frequency are three different quantities.
- Published pricing
- $297 / month listed
- Price conditions
- Compounded semaglutide injection program; confirm current availability
- Checked
- October 10, 2026
What stands out
- Monthly and prepaid terms published
- Injection and oral routes separated
- Shipment intervals disclosed
What to weigh
- The program terms page has an older publication date and needs checkout confirmation.
- No hands-on treatment or support testing
Why we start with the program terms
Henry Meds’ legal program page is more specific than a generic weight-loss headline. It lists distinct programs for injectable and non-injectable medicines, with prices and supply intervals. We accessed it on October 10, 2026, but the page itself says it was last updated December 3, 2025. That distinction is why the figures here are published terms requiring confirmation, not a verified current checkout.[source]
Some headings and descriptions in the oral-program section are internally inconsistent. We have not resolved those by guessing or transferred those quantities into an injectable review. A written quote for the intended route is preferable to assuming a similarly named program is interchangeable.
What the semaglutide schedule says
The injection program lists $297 monthly, with alternative shipment descriptions spanning 70 or 90 days. It also lists six months at $1,782, or $1,482 when paid in full, and twelve months at $3,564, or $2,364 paid in full. The prepaid arithmetic is $247 and $197 per month respectively. Those lower averages require different commitments.[source]
The key comparison is not just $197 versus $297. It is the cash paid now, what is supplied, the later shipment schedule and what happens if the clinician changes or stops treatment. A monthly charge does not mean a new shipment arrives every month.
Do not move evidence between formulations
The same terms page lists sublingual semaglutide programs. A dissolving tablet or drop is not the same formulation as an approved oral medicine, and it is not an injectable prescription without the needle. This review does not assign branded-drug trial outcomes to Henry’s compounded preparations.[source][source]
FDA emphasizes that compounded products are not approved for safety, effectiveness and quality. The prescriber should explain the individualized medical reason for the proposed preparation. Availability on a program list is not evidence that every reader qualifies.
The questions that decide practical value
Ask for a current itemized quote naming the medication, route, quantity, shipping schedule, supplies and total prepaid amount. Then obtain the cancellation and refund terms before paying for a longer period. The published program schedule is useful for preparing that conversation, but it does not answer every contingency.
We would compare Henry Meds with a service offering the same proposed route and care needs, rather than with the lowest number on an unrelated medicine page. Read the injection-program analysis for the distinction between shipment timing and monthly cost.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Henry Meds: program terms and supply periodsTerms page checked October 10, 2026; page itself dated December 3, 2025. Availability must be confirmed. · Checked October 10, 2026
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags · Checked October 10, 2026